ENDRA Life Sciences Strengthens TAEUS® Platform with New Patent
ENDRA Life Sciences Inc. (NASDAQ: NDRA) has recently announced a significant advancement in its intellectual property portfolio with the issuance of its 17th European patent. Titled EP4247282, this patent highlights a groundbreaking "Method and System for Monitoring Tissue Temperature," which promises to revolutionize surgical procedures.
Innovative Method for Thermal Surgical Interventions
The newly awarded patent pertains to an innovative approach in monitoring tissue ablation during minimally invasive thermal surgical interventions using ENDRA's TAEUS® system. This system not only enhances surgical precision but also addresses a critical need in healthcare for effective monitoring methods.
ENDRA's patented method is particularly relevant to the growing prevalence of minimally invasive microwave and radiofrequency thermal ablation, providing significant benefits over traditional open surgical procedures. These benefits include reducing patient discomfort and shortening recovery periods, essential factors that enhance patient care.
Enhancing the Intellectual Property Portfolio
Alexander Tokman, ENDRA's Chief Executive Officer, expressed his satisfaction with the issuance of this patent, stating, "This issued patent supports our strategy to develop optimized hybrid ultrasound and thermoacoustic imaging systems and to broaden the potential applications for our TAEUS® platform technology in areas with unmet clinical needs." This reflects ENDRA's ongoing commitment to advancing its technology.
With the new patent, ENDRA is well-positioned to protect its innovations in key global markets including the USA, Europe, and China, ensuring the sustainability and competitiveness of its offerings. Currently, ENDRA's intellectual property encompasses a robust collection of 82 patents issued worldwide, underscoring its dedication to innovation.
About ENDRA Life Sciences and Its Technology
ENDRA Life Sciences is recognized as a pioneer in Thermo Acoustic Enhanced UltraSound (TAEUS®), a transformative technology that enables the characterization of tissue at a fraction of the cost of traditional methods, akin to MRI. This technology is specifically designed for non-invasive assessments of fatty tissue in the liver.
Non-alcoholic fatty liver disease (NAFLD), which falls under the umbrella of steatotic liver disease (SLD), poses a global health challenge, impacting over two billion individuals. Unfortunately, practical diagnostic tools are still lacking in this domain. ENDRA's TAEUS® offers innovative solutions not only in liver diagnostics but also in various other clinical applications, including non-invasive techniques for visualizing tissue temperature during energy-based surgical interventions.
Looking Ahead
As ENDRA Life Sciences continues to pursue the frontiers of medical technology, its focus on enhancing patient care through innovative solutions remains unwavering. The TAEUS® platform stands out as a testament to ENDRA’s vision of providing advanced medical diagnostics and interventions that meet the needs of healthcare professionals and patients alike.
Frequently Asked Questions
What is ENDRA Life Sciences known for?
ENDRA Life Sciences is recognized for pioneering Thermo Acoustic Enhanced UltraSound (TAEUS®) technology, which offers cost-effective and non-invasive tissue characterization.
What does the new patent EP4247282 cover?
The patent pertains to a method and system for monitoring tissue temperature during thermal surgical interventions, enhancing minimally invasive surgical practices.
How does TAEUS® benefit patients undergoing surgery?
TAEUS® improves monitoring during procedures, leading to less pain and faster recovery times compared to traditional open surgery methods.
How extensive is ENDRA's intellectual property portfolio?
ENDRA currently holds an impressive portfolio of 82 patents globally, reaffirming its commitment to innovation and protecting its technological advancements.
Where can I learn more about ENDRA Life Sciences?
For more information about ENDRA Life Sciences and its groundbreaking technologies, visit their official website.
